C arbon dioxide (CO 2 ) is the most important regulator of respiration and blood pH. Papers are published with scant new information every so often that largely focus on clinical descriptions of hypercapnic individuals, often obese. While there is intense basic science interest in CO 2 sensitive neurons in the brainstem, including the Phox2b/neurokinin-1 receptor (NK1R)-expressing neurons in the pre-Bötzinger complex (pre-BötzC), 1 and exposing the carotid bodies to hypocapnia induces periodic breathing, 2,3 the science and industry of sleepbreathing medicine has generally neglected CO 2 . Much of the information on chronic exposure to elevated but low levels of CO 2 comes from submarine research, targeting sustained ambient concentrations in the low single digits.4-8 Acute exposure to high concentrations of CO 2 results in extreme dyspnea and death; the gas has anesthetic properties and can induce a reversible isoelectric EEG. 9 Demonstrating slowing of EEG rhythms with hypercapnia 10 and power loss in classic oscillatory bands 11 (besides increased slow wave sleep associated with respiratory failure 12 ) is nonspecifi c and not informative on pathobiological mechanisms. Increased inhaled CO 2 does suppress cerebral metabolic rate of oxygen 13 and reduces resting state functional connectivity.14 While sympathetic drive is reliably increased acutely by hypercapnia, acclimatization mechanisms at the cellular and neural circuit levels, which can be remarkably potent enabling life at otherwise lethal CO 2 levels, remain to be elucidated. We are not sure if there is a true CO 2 sensor equivalent to hypoxia-inducible factors vs. simply pH mediated changes, or if there are profound direct effects of CO 2 on infl ammatory responses, the metabolome, the transcriptome, or epigenetic regulation. Widespread systemic dysregulation is plausible, and some data is suggestive. Hypercapnia can induce mitochondrial dysfunction through increased levels on microRNA-183, which decreases expression of isocitrate dehydrogenase.15 Hypoxia-hypercapnia cycles are neurotoxic.
16Obesity hypoventilation (vs. obese controls) was reported to show an increase in the pro-atherosclerotic RANTES chemokine, a decrease in the anti-infl ammatory adipokine adiponectin, and impaired endothelial function.
17The paper by Wang et al. is a timely reminder that we neglect CO 2 to our peril.18 Though the study was not primarily designed to answer the specifi c question of CO 2 and EEG/sleepiness/ cognition, and the therapeutic precision could have been better, the data strongly suggest an adverse and partially reversible impact of hypercapnia on brain function in the context of sleep disordered breathing. Detailed neurocognitive assessments were not reported, and if done, perhaps will be in another publication. Hypercapnia will be seen increasingly in association with obesity in children and adults, and a range of hypoventilation syndromes from neuromuscular or pulmonary disorders. Do we have a relatively silent "hypercapnic dementia" epidemic coming, just ...